IL22 and type 1 diabetes mellitus: Some of the islet-transplanted T1D mice also received recombinant IL-22 (100 ng kg−1 body weight twice weekly via intravenous injection) beginning day 12 post-transplantation and continuing for up to 50 days post-transplantation.